Associations Between Weight Loss and Gastrointestinal Adverse Events on GLP-1RA Therapy While gastrointestinal adverse events that occur with GLP-1RAs are mainly mild-to-moderate and transient, occurring particularly during dose escalation, there may be concerns that GLP-1RA-mediated weight loss could be due to these effects
Mol Endocrinol 18:18591875 Ortega I, Sokalska A, Villanueva JA, Cress AB, Wong DH, Stener VE, Scott D, Stanley SD, Duleba AJ (2013) Letrozole increases ovarian growth and Cyp17a1
2Inject slowly down the vial wall
This classification places Retatrutide within a broader field of metabolic research peptides, especially compounds used to investigate incretin biology, glucagon receptor signaling, receptor selectivity, pathway integration, and structureactivity relationships